ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

FLUOXETINUM

Active substance (INN) · ATC N06AB03 · 3 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
D11AH-L04AA	DERMATITA ATOPICĂ - AGENŢI BIOLOGICI: DUPILUMABUM1Ω ȘI INHIBITORI DE JAK: BARICITINIBUM1Ω, UPADACITINIBUM (15 mg, 30 mg)1Ω, ABROCITINIBUM1Ω	In force	mentioned in the text	C1-G31G	NO
N07XX06	TETRABENAZINUM	In force	mentioned in the text	C1-G12	NO
N07XX11	PITOLISANTUM	In force	mentioned in the text	C1-G12	NO

History: entries into and exits from protocols

Month	Type	Code	Protocol	Level
January 2026	Medicine added	D11AH-L04AA	DERMATITA ATOPICĂ - AGENŢI BIOLOGICI: DUPILUMABUM1Ω ȘI INHIBITORI DE JAK: BARICITINIBUM1Ω, UPADACITINIBUM (15 mg, 30 mg)**1Ω, ABROCITINI	mentioned in the text

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
FLUOXETIN ARENA 10 mg	CAPS.	10mg	ARENA GROUP S.A. - ROMANIA	N06AB03	PRF
FLUOXETIN ARENA 20 mg	CAPS.	20mg	ARENA GROUP S.A. - ROMANIA	N06AB03	PRF
FLUOXIN 20 mg	CAPS.	20mg	VIM SPECTRUM S.R.L. - ROMANIA	N06AB03	PRF

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.